183 related articles for article (PubMed ID: 11053449)
1. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway.
Chang WT; Kang JJ; Lee KY; Wei K; Anderson E; Gotmare S; Ross JA; Rosen GD
J Biol Chem; 2001 Jan; 276(3):2221-7. PubMed ID: 11053449
[TBL] [Abstract][Full Text] [Related]
2. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells.
Kiviharju TM; Lecane PS; Sellers RG; Peehl DM
Clin Cancer Res; 2002 Aug; 8(8):2666-74. PubMed ID: 12171899
[TBL] [Abstract][Full Text] [Related]
4. PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells.
Lee KY; Chang W; Qiu D; Kao PN; Rosen GD
J Biol Chem; 1999 May; 274(19):13451-5. PubMed ID: 10224110
[TBL] [Abstract][Full Text] [Related]
5. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation.
Lee KY; Park JS; Jee YK; Rosen GD
Exp Mol Med; 2002 Dec; 34(6):462-8. PubMed ID: 12526088
[TBL] [Abstract][Full Text] [Related]
6. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.
Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H
Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982
[TBL] [Abstract][Full Text] [Related]
7. Triptolide induces growth inhibition and apoptosis of human laryngocarcinoma cells by enhancing p53 activities and suppressing E6-mediated p53 degradation.
Zhao F; Huang W; Ousman T; Zhang B; Han Y; Clotaire DZ; Wang C; Chang H; Luo H; Ren X; Lei M
PLoS One; 2013; 8(11):e80784. PubMed ID: 24244715
[TBL] [Abstract][Full Text] [Related]
8. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy.
Fidler JM; Li K; Chung C; Wei K; Ross JA; Gao M; Rosen GD
Mol Cancer Ther; 2003 Sep; 2(9):855-62. PubMed ID: 14555704
[TBL] [Abstract][Full Text] [Related]
9. Triptolide has anticancer and chemosensitization effects by down-regulating Akt activation through the MDM2/REST pathway in human breast cancer.
Xiong J; Su T; Qu Z; Yang Q; Wang Y; Li J; Zhou S
Oncotarget; 2016 Apr; 7(17):23933-46. PubMed ID: 27004407
[TBL] [Abstract][Full Text] [Related]
10. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
[TBL] [Abstract][Full Text] [Related]
11. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis.
Panichakul T; Intachote P; Wongkajorsilp A; Sripa B; Sirisinha S
Anticancer Res; 2006; 26(1A):259-65. PubMed ID: 16475706
[TBL] [Abstract][Full Text] [Related]
12. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
Huang M; Zhang H; Liu T; Tian D; Gu L; Zhou M
Mol Cancer Ther; 2013 Feb; 12(2):184-94. PubMed ID: 23243057
[TBL] [Abstract][Full Text] [Related]
13. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas.
Wu J; Li QQ; Zhou H; Lu Y; Li JM; Ma Y; Wang L; Fu T; Gong X; Weintraub M; Wu S; Ding H
Med Oncol; 2014 Jul; 31(7):14. PubMed ID: 24880464
[TBL] [Abstract][Full Text] [Related]
14. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
[TBL] [Abstract][Full Text] [Related]
15. Synergistic cytotoxicity and apoptosis induced in human cholangiocarcinoma cell lines by a combined treatment with tumor necrosis factor-alpha (TNF-alpha) and triptolide.
Panichakul T; Wanun T; Reutrakul V; Sirisinha S
Asian Pac J Allergy Immunol; 2002 Sep; 20(3):167-73. PubMed ID: 12587840
[TBL] [Abstract][Full Text] [Related]
16. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.
Wan CK; Wang C; Cheung HY; Yang M; Fong WF
Cancer Lett; 2006 Sep; 241(1):31-41. PubMed ID: 16316721
[TBL] [Abstract][Full Text] [Related]
17. Triptolide sensitizes breast cancer cells to Doxorubicin through the DNA damage response inhibition.
Deng Y; Li F; He P; Yang Y; Yang J; Zhang Y; Liu J; Tong Y; Li Q; Mei X; Shu Z; Zhao Q
Mol Carcinog; 2018 Jun; 57(6):807-814. PubMed ID: 29500880
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressant PG490 (triptolide) induces apoptosis through the activation of caspase-3 and down-regulation of XIAP in U937 cells.
Choi YJ; Kim TG; Kim YH; Lee SH; Kwon YK; Suh SI; Park JW; Kwon TK
Biochem Pharmacol; 2003 Jul; 66(2):273-80. PubMed ID: 12826269
[TBL] [Abstract][Full Text] [Related]
20. NF-κB signaling inhibition and anticancer activities of LLDT-246 on human colorectal cancer HCT-116 cells in vitro.
Li M; Wang X; Liu M; Qi X; Li J
Biomed Pharmacother; 2014 Jun; 68(5):527-35. PubMed ID: 24986326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]